Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma.
Tong C, Zhang Y, Liu Y, Ji X, Zhang W, Guo Y, Han X, Ti D, Dai H, Wang C, Yang Q, Liu W, Wang Y, Wu Z, Han W.
Tong C, et al.
Blood. 2020 Oct 1;136(14):1632-1644. doi: 10.1182/blood.2020005278.
Blood. 2020.
PMID: 32556247
Free PMC article.
Clinical Trial.